Dr.Datsons Labs Ltd

Dr.Datsons Labs Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Dr.Datsons Labs Ltd

₹ 6.40 -4.48%
21 May 2015
Company website BSE: 533412
About

Dr.Datsons Labs Ltd is an India-based integrated pharmaceutical company. The company is engaged in the manufacturing and marketing capabilities in contract research and manufacturing services, and active pharmaceutical ingredients.

[ add key points ]
Website BSE
  • Market Cap ₹ Cr.
  • Current Price ₹ 6.40
  • High / Low ₹ /
  • Stock P/E
  • Book Value ₹ 50.2
  • Dividend Yield 0.00 %
  • ROCE 5.03 %
  • ROE 0.19 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Stock is trading at 0.13 times its book value

Cons

  • Company has low interest coverage ratio.
  • Company has a low return on equity of 9.06% over last 3 years.
  • Earnings include an other income of Rs.17.1 Cr.
  • Dividend payout has been low at 8.42% of profits over last 3 years
  • Company has high debtors of 317 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2009 Mar 2013 Jun 2013 Sep 2013 Dec 2013 Mar 2014 Jun 2014 Sep 2014 Dec 2014
30.87 73.91 117.69 132.00 150.57 20.79 201.44 114.03 171.12
25.39 67.70 96.90 114.99 130.00 22.11 191.42 108.43 165.90
Operating Profit 5.48 6.21 20.79 17.01 20.57 -1.32 10.02 5.60 5.22
OPM % 17.75% 8.40% 17.67% 12.89% 13.66% -6.35% 4.97% 4.91% 3.05%
0.00 -45.41 0.00 -0.14 0.00 7.83 0.00 4.37 4.92
Interest 1.16 9.93 11.74 8.31 12.67 10.29 8.69 8.68 8.85
Depreciation 0.20 5.42 5.10 5.15 5.15 5.04 1.25 1.26 1.26
Profit before tax 4.12 -54.55 3.95 3.41 2.75 -8.82 0.08 0.03 0.03
Tax % 30.10% -30.03% 18.23% 48.97% 32.36% -30.27% 37.50% 33.33% 33.33%
2.88 -38.17 3.24 1.74 1.86 -6.15 0.06 0.02 0.02
EPS in Rs -27.49 2.33 1.25 1.34 -1.94 0.01 0.00 0.00
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 TTM
0 22 90 162 320 480 521 421 507
0 17 79 132 250 375 415 364 488
Operating Profit 0 5 11 29 71 105 106 57 20
OPM % 22% 12% 18% 22% 22% 20% 14% 4%
0 0 0 1 0 2 -40 8 17
Interest 0 1 3 6 14 29 43 43 37
Depreciation 0 0 1 1 3 16 20 20 9
Profit before tax 0 4 8 23 55 63 3 1 -9
Tax % 37% 35% 34% 34% 35% 80% 48%
0 2 5 15 36 41 1 1 -6
EPS in Rs 29.55 0.40 0.21 -1.93
Dividend Payout % 0% 0% 0% 0% 0% 25% 0%
Compounded Sales Growth
10 Years: %
5 Years: 36%
3 Years: 10%
TTM: 7%
Compounded Profit Growth
10 Years: %
5 Years: -33%
3 Years: -74%
TTM: -144%
Stock Price CAGR
10 Years: -6%
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: 13%
3 Years: 9%
Last Year: 0%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Sep 2014
Equity Capital 0 2 5 6 8 14 14 32 53
Reserves -0 2 7 44 127 336 296 376 475
1 12 38 60 139 299 550 495 366
0 11 11 25 22 70 186 360 164
Total Liabilities 1 28 61 135 295 718 1,045 1,263 1,058
0 11 13 47 70 214 208 188 186
CWIP 1 0 0 4 47 144 164 179 343
Investments 0 0 0 0 0 1 2 213 213
0 17 47 84 178 359 670 683 316
Total Assets 1 28 61 135 295 718 1,045 1,263 1,058

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014
0 -2 -22 1 -46 -46 40 135
-1 -11 -3 -39 -68 -256 -36 -226
1 13 26 38 114 305 205 -120
Net Cash Flow 0 0 1 0 -0 3 208 -211

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014
Debtor Days 205 125 98 103 153 191 317
Inventory Days 63 76 107 129 142 157 194
Days Payable 0 0 46 -9 41 150 326
Cash Conversion Cycle 269 201 158 242 253 198 185
Working Capital Days 110 150 135 183 228 202 293
ROCE % 52% 31% 36% 36% 20% 12% 5%

Shareholding Pattern

Numbers in percentages

Shareholding pattern is currently not available for this company.

Documents

Announcements

All

No data available.

Annual reports

Credit ratings